Mirum Pharmaceuticals Cash from Operations (Quarterly) Insights

Mirum Pharmaceuticals Inc (MIRM)

46.26 +2.34 (+5.33%) USD | NASDAQ | Nov 14, 16:00

48.11 +1.85 (+4.00%) After-Hours: 07:07

Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2019. Upgrade now.

Date	Value
June 30, 2024	-3.803M
March 31, 2024	15.21M
December 31, 2023	-16.62M
September 30, 2023	-18.22M
June 30, 2023	-17.33M
March 31, 2023	-18.77M
December 31, 2022	-34.27M
September 30, 2022	-26.02M
June 30, 2022	-20.17M
March 31, 2022	-39.67M
December 31, 2021	-33.15M

Date	Value
September 30, 2021	-34.20M
June 30, 2021	-40.20M
March 31, 2021	-25.21M
December 31, 2020	-36.28M
September 30, 2020	-17.45M
June 30, 2020	-16.99M
March 31, 2020	-18.35M
December 31, 2019	-13.70M
September 30, 2019	-15.22M
June 30, 2019	-8.017M
March 31, 2019	-2.426M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

-40.20M

Minimum

Jun 2021

15.21M

Maximum

Mar 2024

-21.85M

Average

-18.77M

Median

Mar 2023

Cash from Operations (Quarterly) Benchmarks

Arcutis Biotherapeutics Inc	-34.69M
Cytokinetics Inc	-101.50M
Amicus Therapeutics Inc	-22.97M
MannKind Corp	9.331M
TG Therapeutics Inc	-12.20M

Cash from Operations (Quarterly) Related Metrics

Cash from Investing (Quarterly)	-72.72M
Cash from Financing (Quarterly)	7.291M
Free Cash Flow	-39.22M
Free Cash Flow Per Share (Quarterly)	-0.3087
Free Cash Flow to Equity (Quarterly)	-14.99M
Free Cash Flow to Firm (Quarterly)	-14.50M
Free Cash Flow Yield	-1.86%